Anti-LFA-1α reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 279-284

  Harrison, Paul C ^a   Madwed, Jeffrey B ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ALLOGRAFT; ANIMAL MODEL; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032914791     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00065-5     Document Type: Article

References (28)

1. Flavin T., Ivens K., Rothlein R., et al. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys. Transplant Proc. 23:1991;533-534.
2. Harihara Y., Sugawara Y., Inoue K., et al. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts. Transplant Proc. 28:1996;1368-1369.
3. Hourmant M., Le Mauff B., Le Meur Y., et al. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. Transplantation. 58:1994;377-380.
4. Isobe M., Yagita H., Okumura K., et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science. 255:1992;1125-1127.
5. Isobe M., Ihara A. Tolerance induction against cardiac allograft by anti-CD18 MAb and anti-LFA-1 treatment T cells respond to in vitro allostimulation . Transplant Proc. 25:1993;1079-1080.
6. Jendrisak M., Jendrisak G., Gamero J., et al. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1 and CD4. Transplant Proc. 25:1993;825-827.
7. Kameoka H., Ishibashi M., Tamatani T., et al. Comparative immunosuppressive effect of anti-CD18 and anti-CD11a monoclonal antibodies on rat heart allotransplantation. Transplant Proc. 25:1993;833-836.
8. Kameoka H., Ishibashi M., Tamatani T., et al. The immunosuppressive action of anti-CD18 monoclonal antibody in rat heterotopic heart allotransplantation. Transplantation. 55:1993;665-667.
9. Kobayashi H., Miyano T., Yamataka A., et al. Prolongation of rat cardiac allograft survival by a monoclonal antibody; anti-rat intercellular adhesion molecule-1. Cardiovas Surg. 1:1993;577-582.
10. Komori A., Nagata M., Ochiai T., et al. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Transplant Proc. 25:1993;831-832.
11. Le Mauff B., Hourmant M., Rougier J.P., et al. Effect of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation. 52:1991;291-296.
12. Paul L.C., Davidoff A., Benediktsson H., et al. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation. 55:1993;1196-1199.
13. Schowengerdt K.O., Zhu J.Y., Stepkowski S.M., et al. Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1. Circulation. 92:1995;82-87.
14. Fischer A, Cavazzana-Calvo M, Jabado N, et al. Monoclonal antibodies to adhesion molecules in bone marrow and organ transplantation. In: Chatenoud L, ed. Monoclonal antibodies in transplantation. Austin, TX: R.G. Landes Co.; 1995, pp. 137-53.
15. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-433.
16. Van Seventer G.A., Shimizu Y., Horgan K.J., et al. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol. 144:1990;4579-4586.
17. Merluzzi VJ, Rothlein R, Wood C, et al. Inhibition of human mixed lymphocyte reactions by monoclonal antibodies to intercellular adhesion molecule-1 (ICAM-1). In: Springer TA, Anderson DC, Rosenthal AS, Rothlein R, eds. Leukocyte adhesion molecules. New York: Springer-Verlag; 1990, pp. 244-53.
18. Stepkowski S.M., Tu Y., Condon T.P., et al. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol. 153:1994;5336-5346.
19. Stepkowski S.M., Tu Y., Condon T.P., et al. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies. Transplant Proc. 27:1995;113.
20. Poston R.S., Mann M., Clark L., et al. Ex vivo gene therapy and MAb LFA-1 combine to yield tolerance to cardiac allograft. J Heart Lung Transplant. 16:1997;41.
21. Gill T.J., Kunz H.W., Misra D.N., et al. The major histocompatibility complex of the rat. Transplantation. 43:1987;773-775.
22. Klempnauer J., Steiniger B., Lück R., et al. Genetic control of rat allograft rejection: effect of different MHC and non-MHC incompatibilities. Immunogenetics. 30:1989;81-88.
23. Guttmann R.D. Immunologic models to study cardiac allograft rejection and prolongation. Transplant Proc. 8:1976;31-35.
24. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225-229.
25. Harrison P.C., Mainolfi E., Madwed J.B. Cyclosporine A dosage can be reduced when used in combination with an anti-ICAM-1 MAb in heterotopic cardiac transplanted rats. J Heart Lung Transplant. 17:1998;150-157.
26. Ma X.L., Lefer D.J., Lefer A.M., et al. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:1992;937-946.
27. Horgan M.J., Ge M., Gu J., et al. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol. 261:1991;H1578-H1584.
28. Byrne J.G., Murphy M.P., Smith W.J., et al. Prevention of CD18-mediated reperfusion injury enhances the efficacy of UW solution for 15-hr heart preservation. J Surg Res. 54:1993;625-630.